Hot Topics
Explosion Accidents:
"Pooch alive after
Breck blast"
– Denver Post
"Baxter to Proceed with Recall of Remaining Heparin Sodium Vial Products"
– FDA
Yamaha Rhino ATV Rollover Accidents
and Injuries
"UBS Hit by
Another Lawsuit"
– Ben Levinsohn, BusinessWeek
"Hedge Funds
Frozen Shut"
– Matthew Goldstein, BusinessWeek
"MRI Contrast Can Cause Disease – Gadolinium Blamed
For Problems"
– Dayle Cedars
7News, Denver, CO
Results
$690,000,000
Global settlement with Eli Lilly and Company regarding its product Zyprexa negotiated by a plaintiffs' attorney group including members of Burg Simpson.
$5,800,000
Hines, et al, vs. Cody Gas Company, et al: verdict for injuries, damages, losses from gas explosion.
CLICK HERE FOR MORE INFORMATION
Our Offices
40 Inverness Drive East
Denver, CO 80112
Phone: 303.792.5595
Fax: 303.708.0527
WYOMING OFFICE
Phone: 307.527.7891
Fax: 307.527.7897
OHIO OFFICE
Phone: 513.852.5600
Fax: 513.852.5611
DALLAS OFFICE
Phone: 972.934.1313
Fax: 972.231.3983
ARIZONA OFFICE
Phone: 602.508.6040
WASHINGTON D.C. OFFICE
Phone: 202.544.7600
Home > Defective Drugs > Trileptal
Trileptal Lawyers
in Denver and Nationwide
In January 2000, the FDA approved the use of Trileptal for the United States market. Trileptal is a drug used for treatment of partial seizures in epileptic adults and children over the age of four, although the FDA approved the use of Trileptal in children as young as two. Trileptal is often prescribed off-label to treat mood disorders.
Trileptal's label was changed in April 2005, to add warnings about serious dermatological reactions, including Stevens-Johnson Syndrome (SJS) and toxic epidermal necrolysis (TEN) which have been reported in both adults and children using Trileptal. Additionally, the "Precautions" section of the label has been updated to include language regarding multi-organ hypersensitivity reactions reported with Trileptal use. Novartis sent a "Dear Doctor" letter in April 2005, advising physicians of the increased risks.
Click here to read the recent decision from the Eastern District of Kentucky which denied Novartis' motion to dismiss based on preemption argument.
If you believe you have a claim because you used Trileptal, please call or email us today for a free consultation. At Burg Simpson Eldredge Hersh & Jardine, P.C., our Colorado dangerous drugs attorneys represent people who have suffered injuries because of Trileptal.
Return to the Defective Drugs Section
